Health System Costs of Treating Latent Tuberculosis Infection With Four Months of Rifampin Versus Nine Months of Isoniazid in Different Settings.
CONCLUSION: A 4-month rifampin regimen was safer and less expensive than 9 months of isoniazid in all settings. This regimen could be adopted by tuberculosis programs in many countries as first-line therapy for latent tuberculosis infection.
PRIMARY FUNDING SOURCE: Canadian Institutes of Health Research.
PMID: 32539440 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Bastos ML, Campbell JR, Oxlade O, Adjobimey M, Trajman A, Ruslami R, Kim HJ, Baah JO, Toelle BG, Long R, Hoeppner V, Elwood K, Al-Jahdali H, Apriani L, Benedetti A, Schwartzman K, Menzies D Tags: Ann Intern Med Source Type: research
More News: African Health | Australia Health | Benin Health | Brazil Health | Canada Health | Children | Clinical Trials | Epidemiology | Ghana Health | Guinea Health | Health Management | Indonesia Health | Internal Medicine | Men | Middle East Health | Pediatrics | Saudi Arabia Health | South Korea Health | Tuberculosis